AIT Therapeutics Reports Financial Results for Fiscal Second Quarter 2019

Nov 14, 2018 4:01pm EST

AIT Therapeutics to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Nov 05, 2018 8:00am EST

AIT Therapeutics Schedules Fiscal Second Quarter 2019 Financial Results Conference Call and Webcast

Oct 31, 2018 4:30pm EDT

AIT Therapeutics Appoints Douglas J. Beck as Chief Financial Officer

Oct 26, 2018 8:00am EDT

AIT Therapeutics Presented Its High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference

Oct 18, 2018 5:12pm EDT

AIT Therapeutics to Present High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference

Oct 16, 2018 5:27pm EDT

AIT Therapeutics to Present at the Ladenburg 4th Annual Healthcare Conference

Sep 26, 2018 8:00am EDT

AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018

Sep 19, 2018 8:00am EDT

AIT Therapeutics Announces $526,500 Sale of Common Stock To Institutional Investor, Lincoln Park Capital Fund

Sep 05, 2018 8:00am EDT

AIT Therapeutics to Present Nitric Oxide Data at Two Upcoming Scientific Conferences

Sep 04, 2018 8:00am EDT